{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T17:49:18Z","timestamp":1772646558971,"version":"3.50.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,4]]},"DOI":"10.7759\/cureus.104657","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T14:47:43Z","timestamp":1772635663000},"source":"Crossref","is-referenced-by-count":0,"title":["Topical Tacrolimus as a Novel Treatment for Refractory Idiopathic Facial Aseptic Granuloma in a Pediatric Patient"],"prefix":"10.7759","author":[{"given":"Terry","family":"Henry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace","family":"Staes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shivam","family":"Gulhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohannad","family":"Al-Samarraie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikisha","family":"Richards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annder.2023.02.005","article-title":"Idiopathic facial aseptic granuloma in children: management and long-term follow-up","volume":"150","author":"Da Silva Dias V","year":"2023","unstructured":"Da Silva Dias V, Lafargue O, Dompmartin A. Idiopathic facial aseptic granuloma in children: management and long-term follow-up. Ann Dermatol Venereol. 2023, 150:173-9. 10.1016\/j.annder.2023.02.005","journal-title":"Ann Dermatol Venereol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/pde.15571","article-title":"Idiopathic aseptic facial granuloma: a retrospective study of 43 cases","volume":"41","author":"Kuperman Wilder L","year":"2024","unstructured":"Kuperman Wilder L, Lamberti A, Boggio P, Abad ME, Luna PC, Larralde M. Idiopathic aseptic facial granuloma: a retrospective study of 43 cases. Pediatr Dermatol. 2024, 41:243-6. 10.1111\/pde.15571","journal-title":"Pediatr Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1080\/08998280.2023.2210964","article-title":"Idiopathic facial aseptic granuloma: case series and review of histological findings","volume":"36","author":"Weir SA","year":"2023","unstructured":"Weir SA, Amin S, Higgins A, Kelly D, Theos A. Idiopathic facial aseptic granuloma: case series and review of histological findings. Proc (Bayl Univ Med Cent). 2023, 36:458-60. 10.1080\/08998280.2023.2210964","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"ref4","unstructured":"Benign lesions of the external periocular tissues. a tutorial. (2017). Accessed: 2025: https:\/\/webeye.ophth.uiowa.edu\/eyeforum\/tutorials\/benign-lid-lesions\/index.htm#gsc.tab=0."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.oftale.2020.07.008","article-title":"Eyelid nodules in idiopathic facial aseptic granuloma","volume":"96","author":"Galindo-Ferreiro A","year":"2021","unstructured":"Galindo-Ferreiro A, Marqu\u00e9s-Fern\u00e1ndez VE, Ju\u00e1rez Mart\u00edn \u00c1, Gonz\u00e1lez-M\u00e1rquez PI, Vega-Guti\u00e9rrez J. Eyelid nodules in idiopathic facial aseptic granuloma. Arch Soc Esp Oftalmol (Engl Ed). 2021, 96:556-60. 10.1016\/j.oftale.2020.07.008","journal-title":"Arch Soc Esp Oftalmol (Engl Ed)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1470.2011.01689.x","article-title":"Should idiopathic facial aseptic granuloma be considered granulomatous rosacea? Report of three pediatric cases","volume":"30","author":"Neri I","year":"2013","unstructured":"Neri I, Raone B, Dondi A, Misciali C, Patrizi A. Should idiopathic facial aseptic granuloma be considered granulomatous rosacea? Report of three pediatric cases. Pediatr Dermatol. 2013, 30:109-11. 10.1111\/j.1525-1470.2011.01689.x","journal-title":"Pediatr Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3928\/01913913-20160511-03","article-title":"Comparative clinical outcomes of pediatric patients presenting with eyelid nodules of idiopathic facial aseptic granuloma, hordeola, and chalazia","volume":"53","author":"Ozer PA","year":"2016","unstructured":"Ozer PA, Gurkan A, Kurtul BE, Kabatas EU, Beken S. Comparative clinical outcomes of pediatric patients presenting with eyelid nodules of idiopathic facial aseptic granuloma, hordeola, and chalazia. J Pediatr Ophthalmol Strabismus. 2016, 53:206-11. 10.3928\/01913913-20160511-03","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/pde.13492","article-title":"Idiopathic facial aseptic granuloma-a diagnostic challenge in pediatric dermatology","volume":"35","author":"Borok J","year":"2018","unstructured":"Borok J, Holmes R, Dohil M. Idiopathic facial aseptic granuloma-a diagnostic challenge in pediatric dermatology. Pediatr Dermatol. 2018, 35:490-3. 10.1111\/pde.13492","journal-title":"Pediatr Dermatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-9740.2007.06485.x","article-title":"Tacrolimus in dermatology-pharmacokinetics, mechanism of action, drug interactions, dosages, and side effects: part I","volume":"7","author":"Sehgal VN","year":"2008","unstructured":"Sehgal VN, Srivastava G, Dogra S. Tacrolimus in dermatology-pharmacokinetics, mechanism of action, drug interactions, dosages, and side effects: part I. Skinmed. 2008, 7:27-30. 10.1111\/j.1540-9740.2007.06485.x","journal-title":"Skinmed"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/DAD.0000000000001118","article-title":"Pilomatrixoma: a comprehensive review of the literature","volume":"40","author":"Jones CD","year":"2018","unstructured":"Jones CD, Ho W, Robertson BF, Gunn E, Morley S. Pilomatrixoma: a comprehensive review of the literature. Am J Dermatopathol. 2018, 40:631-41. 10.1097\/DAD.0000000000001118","journal-title":"Am J Dermatopathol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2008.06.007","article-title":"Eyelid pilomatrixoma: a description of 16 cases and a review of the literature","volume":"53","author":"Levy J","year":"2008","unstructured":"Levy J, Ilsar M, Deckel Y, Maly A, Anteby I, Pe'er J. Eyelid pilomatrixoma: a description of 16 cases and a review of the literature. Surv Ophthalmol. 2008, 53:526-35. 10.1016\/j.survophthal.2008.06.007","journal-title":"Surv Ophthalmol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjps.2025.02.044","article-title":"Pilomatrixoma: a comprehensive 32-year analysis of clinical and histopathological findings of 1235 patients treated at Mayo Clinic","volume":"104","author":"Wan R","year":"2025","unstructured":"Wan R, Adam EA, Pazelli AM, Mardini S, Davis D, Lehman JS, Gibreel W. Pilomatrixoma: a comprehensive 32-year analysis of clinical and histopathological findings of 1235 patients treated at Mayo Clinic. J Plast Reconstr Aesthet Surg. 2025, 104:245-52. 10.1016\/j.bjps.2025.02.044","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/pde.12571","article-title":"Idiopathic facial aseptic granuloma: review of an evolving clinical entity","volume":"32","author":"Zitelli KB","year":"2015","unstructured":"Zitelli KB, Sheil AT, Fleck R, Schwentker A, Lucky AW. Idiopathic facial aseptic granuloma: review of an evolving clinical entity. Pediatr Dermatol. 2015, 32:e136-9. 10.1111\/pde.12571","journal-title":"Pediatr Dermatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2006.07741.x","article-title":"Idiopathic facial aseptic granuloma: a multicentre prospective study of 30 cases","volume":"156","author":"Boralevi F","year":"2007","unstructured":"Boralevi F, L\u00e9aut\u00e9-Labr\u00e8ze C, Lepreux S, Barbarot S, Mazereeuw-Hautier J, Eschard C, Ta\u00efeb A. Idiopathic facial aseptic granuloma: a multicentre prospective study of 30 cases. Br J Dermatol. 2007, 156:705-8. 10.1111\/j.1365-2133.2006.07741.x","journal-title":"Br J Dermatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2230.2000.00628.x","article-title":"Topical tacrolimus in dermatology","volume":"25","author":"Nasr IS","year":"2000","unstructured":"Nasr IS. Topical tacrolimus in dermatology. Clin Exp Dermatol. 2000, 25:250-4. 10.1046\/j.1365-2230.2000.00628.x","journal-title":"Clin Exp Dermatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009864.pub2","article-title":"Topical tacrolimus for atopic dermatitis","volume":"2015","author":"Cury Martins J","year":"2015","unstructured":"Cury Martins J, Martins C, Aoki V, Gois AF, Ishii HA, da Silva EM. Topical tacrolimus for atopic dermatitis. Cochrane Database Syst Rev. 2015, 2015:CD009864. 10.1002\/14651858.CD009864.pub2","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/431725-topical-tacrolimus-as-a-novel-treatment-for-refractory-idiopathic-facial-aseptic-granuloma-in-a-pediatric-patient","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T14:47:44Z","timestamp":1772635664000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/431725-topical-tacrolimus-as-a-novel-treatment-for-refractory-idiopathic-facial-aseptic-granuloma-in-a-pediatric-patient"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,4]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.104657","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,4]]}}}